Cited by 277Sirtuins and Resveratrol in MedicineCardiovascular Health and Disease PreventionPhytochemicals and Antioxidant Activities

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure

Open access
Wong, R.H.X., Howe, P.R.C., Buckley, J.D., Coates, A.M., Kunz, I., Berry, N.M.·2011·Nutrition, Metabolism and Cardiovascular Diseases

Abstract

Background and aims Flow-mediated dilatation of the brachial artery (FMD) is a biomarker of endothelial function and cardiovascular health. Impaired FMD is associated with several cardiovascular risk factors including hypertension and obesity. Various food ingredients such as polyphenols have been shown to improve FMD. We investigated whether consuming resveratrol, a polyphenol found in red wine, can enhance FMD acutely and whether there is a dose-response relationship for this effect.Methods and results 19 overweight/obese (BMI 25-35 kg m(-2)) men or post-menopausal women with untreated borderline hypertension (systolic BP: 130-160 mmHg or diastolic BP: 85-100 mmHg) consumed three doses of resveratrol (resVida™ 30, 90 and 270 mg) and a placebo at weekly intervals in a double-blind, randomized crossover comparison. One hour after consumption of the supplement, plasma resveratrol and FMD were measured. Data were analyzed by linear regression versus log(10) dose of resveratrol. 14 men and 5 women (age 55 ± 2 years, BMI 28.7 ± 0.5 kg m(-2), BP 141 ± 2/89 ± 1 mmHg) completed this study. There was a significant dose effect of resveratrol on plasma resveratrol concentration (P < 0.001) and on FMD (P < 0.01), which increased from 4.1 ± 0.8% (placebo) to 7.7 ± 1.5% after 270 mg resveratrol. FMD was also linearly related to log(10) plasma resveratrol concentration (P < 0.01).Conclusion Acute resveratrol consumption increased plasma resveratrol concentrations and FMD in a dose-related manner. This effect may contribute to the purported cardiovascular health benefits of grapes and red wine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.numecd.2010.03.003

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In obese humans, one week of resveratrol supplementation dose-dependently improved endothelial function and cardiovascular health.

    “Also in human obese subjects endothelial function and cardiovascular health, dose-dependently improved after one week of resveratrol supplementation (Wong et al., 2010).”
  • Wong et al. enrolled 19 overweight/obese patients and postmenopausal women (BMI 25-35 kg/m2, aged 30-70 years) with blood hypertension in a placebo-controlled, double-blind, randomized crossover study.

    “In the same year, Wong and colleagues in their placebo-controlled, double-blind, randomized crossover study enrolled 19 overweight/obese patients and postmenopausal women (BMI 25–35 kg/m2, aged 30–70 years) with blood hypertension [34].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [34]

  • At 270 mg once daily, flow-mediated dilation (FMD) of the brachial artery increased in a dose-related manner.

    “At the dose of 270 mg administered once a day, flow-mediated dilation (FMD) of the brachial artery increased in a dose-related manner [34].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [34]

  • In Wong et al.'s study, there was a linear relationship between the dose of resveratrol administered and its plasma concentrations.

    “The results of this study showed a linear relationship between the dose of resveratrol administered and its plasma concentrations.”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [34]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M.
Affiliations
  • University of South Australia (AU)
  • DSM (Switzerland) (CH)
Corresponding author
  • Wong, R.H.X.
  • Howe, P.R.C.
  • Buckley, J.D.
  • Coates, A.M.
  • Kunz, I.
  • Berry, N.M.
Venue
Nutrition, Metabolism and Cardiovascular Diseases
Publisher
Elsevier BV
Published
2011-11
Volume
21
Issue
11
Pages
851-856
ISSN
0939-4753 (ISSN-L)
OpenAlex
W2158518544
Cited by
277
References
33
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 14 · 2021: 18 · 2020: 15 · 2019: 16 · 2018: 18 · 2017: 22 · 2016: 23 · 2015: 22 · 2014: 25 · 2013: 42 · 2012: 22
FWCI
9.83
Type
journal article
Language
en
Open access
Locations
  • Nutrition Metabolism and Cardiovascular Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
Funders
DNP-DSM Nutritional Products, Kaiseraugst, Switzerland
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
resveratrol, flow-mediated dilation, endothelial function, borderline hypertension, obesity, overweight, polyphenols, dose-response relationship, red wine, cardiovascular health
MeSH terms
Resveratrol, Brachial Artery, Cardiovascular Diseases, Dose-Response Relationship, Drug, Double-Blind Method, Endothelium, Vascular, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Placebos, Risk Factors, Stilbenes, Vasodilation, Cross-Over Studies, Dietary Supplements, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review